Literature DB >> 12671663

The case for early detection.

Ruth Etzioni1, Nicole Urban, Scott Ramsey, Martin McIntosh, Stephen Schwartz, Brian Reid, Jerald Radich, Garnet Anderson, Leland Hartwell.   

Abstract

Early detection represents one of the most promising approaches to reducing the growing cancer burden. It already has a key role in the management of cervical and breast cancer, and is likely to become more important in the control of colorectal, prostate and lung cancer. Early-detection research has recently been revitalized by the advent of novel molecular technologies that can identify cellular changes at the level of the genome or proteome, but how can we harness these new technologies to develop effective and practical screening tests?

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671663     DOI: 10.1038/nrc1041

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  291 in total

1.  Spin electron paramagnetic resonance of albumin for diagnosis of oral squamous cell carcinoma (OSCC).

Authors:  Maximilian Moergel; Peer W Kämmerer; Kerstin Schnurr; Marcus O Klein; Bilal Al-Nawas
Journal:  Clin Oral Investig       Date:  2011-12-09       Impact factor: 3.573

Review 2.  Molecular analysis of blood with micro-/nanoscale field-effect-transistor biosensors.

Authors:  Matthew S Makowski; Albena Ivanisevic
Journal:  Small       Date:  2011-06-03       Impact factor: 13.281

3.  The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

Authors:  Amanda G Paulovich; Jeffrey R Whiteaker; Andrew N Hoofnagle; Pei Wang
Journal:  Proteomics Clin Appl       Date:  2008-10-01       Impact factor: 3.494

Review 4.  Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.

Authors:  Ki Young Choi; Gang Liu; Seulki Lee; Xiaoyuan Chen
Journal:  Nanoscale       Date:  2011-12-01       Impact factor: 7.790

5.  Translating cancer 'omics' to improved outcomes.

Authors:  Emily A Vucic; Kelsie L Thu; Keith Robison; Leszek A Rybaczyk; Raj Chari; Carlos E Alvarez; Wan L Lam
Journal:  Genome Res       Date:  2012-02       Impact factor: 9.043

6.  Self-assembly of random co-polymers for selective binding and detection of peptides.

Authors:  Bo Zhao; Mahalia A C Serrano; Jingjing Gao; Jiaming Zhuang; Richard W Vachet; S Thayumanavan
Journal:  Polym Chem       Date:  2017-12-19       Impact factor: 5.582

Review 7.  Life history trade-offs in cancer evolution.

Authors:  C Athena Aktipis; Amy M Boddy; Robert A Gatenby; Joel S Brown; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2013-11-11       Impact factor: 60.716

8.  Distinct ON/OFF fluorescence signals from dual-responsive activatable nanoprobes allows detection of inflammation with improved contrast.

Authors:  Mathieu L Viger; Guillaume Collet; Jacques Lux; Viet Anh Nguyen Huu; Monica Guma; Alexandra Foucault-Collet; Jason Olejniczak; Shivanjali Joshi-Barr; Gary S Firestein; Adah Almutairi
Journal:  Biomaterials       Date:  2017-03-28       Impact factor: 12.479

Review 9.  Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.

Authors:  M E de Noo; R A E M Tollenaar; A M Deelder; L H Bouwman
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

10.  Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory?

Authors:  Steven A Carr; Leigh Anderson
Journal:  Clin Chem       Date:  2008-11       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.